NIH-funded research R01 grant

Investigating how diet and drugs can affect cancer development in the mouth

Official title: Pharmacological and dietary inhibition of a novel metabolic-epigenetic crosstalk in head and neck cancer

Funded at University of Southern California · NIH-11044055 · Data updated 2026-11-12

This study is looking at how a certain type of cancer in the mouth develops from a condition called leukoplakia, and it aims to find new ways to stop or slow down the cancer using lab-grown tissue models, which could help patients with better treatment options.

More Head and Neck Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Southern California
NIH-funded
Lab location1 site (Los Angeles, UNITED STATES)
Project startMarch 1, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$497,650
NIH project number5R01DE033648-02
Project IDNIH-11044055 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with leukoplakia or those at high risk for developing head and neck cancer.

Less likely to help

Patients with advanced head and neck cancer who are already undergoing treatment may not benefit from this research.

What this research studies

This research focuses on understanding the progression of head and neck squamous cell carcinoma (HNSCC), a serious type of cancer that starts in the mouth's lining. It explores how a specific metabolic pathway and epigenetic changes contribute to the development of this cancer from a premalignant condition called leukoplakia. By using advanced organoid models that mimic human tissue, the researchers aim to identify potential therapeutic targets that could inhibit cancer growth. Patients may benefit from insights gained about dietary and pharmacological interventions that could prevent or slow down cancer progression.

Why it matters

Potential benefit: If successful, this research could lead to new dietary and pharmacological strategies to prevent or treat head and neck cancer.

How similar studies have gone: Previous research has shown promising results in targeting metabolic pathways in cancer treatment, suggesting that this approach could be effective.

Where this research is happening

  • University of Southern California
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Lin, de-Chen — University of Southern California
  • Study coordinator: Lin, de-Chen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.